Abdominal Aortic Aneurysm

Aortic Wall Structure and Biomechanics

• Inflammatory Remodeling and Proteolytic Cascade: The fundamental pathophysiologic mechanism involves chronic inflammation of the aortic wall, characterized by infiltration of macrophages, T lymphocytes, and mast cells. These inflammatory cells produce excessive matrix metalloproteinases (MMP-2, MMP-9), particularly MMP-9, which actively cleave type I and III collagen and elastin—the load-bearing structural proteins of the media. Simultaneously, tissue inhibitors of metalloproteinases (TIMPs) are downregulated, shifting the balance toward proteolysis. This imbalance between protease and antiprotease activity results in progressive loss of the medial elastic lamina and smooth muscle cells, creating a weakened, compliant aortic segment vulnerable to aneurysmal expansion. The inflammatory milieu also includes elevation of TNF-α, IL-6, and oxidative stress markers (reactive oxygen species), which further perpetuate wall degradation and impair smooth muscle cell function.

• Smooth Muscle Cell Dysfunction and Apoptosis: Medial smooth muscle cells (SMCs) undergo progressive apoptosis and dedifferentiation in aneurysmal tissue. Loss of SMC contractile phenotype reduces the active tension-generating capacity of the aortic wall. SMCs normally synthesize collagen and elastin to maintain structural homeostasis; apoptotic loss of these cells impairs regenerative repair mechanisms. Additionally, oxidative stress and inflammatory mediators (particularly TNF-α) activate caspase pathways leading to programmed SMC death. The net result is a self-perpetuating cycle: fewer SMCs produce less structural matrix, requiring remaining cells to bear proportionally greater wall stress, accelerating their dysfunction.

• Elastin Degradation and Elastic Fiber Loss: Elastin comprises 50% of the medial dry weight and is responsible for the aorta's elastic recoil properties. In AAA, fragmentation and loss of elastic fibers occurs through enzymatic degradation by MMPs and through direct oxidative damage. Elastin is minimally renewable in adult tissues; once degraded, elastic fibers are not effectively replaced, contributing to permanent loss of elastic recoil and increased compliance. This irreversible loss drives pathologic aortic dilation even after inflammatory triggers are controlled, explaining why AAAs rarely regress and only grow or remain stable.

• Hemodynamic Stress and Laplace Mechanics: Aneurysmal dilation itself perpetuates wall weakening through geometric amplification of wall stress. The Law of Laplace states that wall stress (σ) is proportional to transmural pressure (ΔP) and aortic radius (r), and inversely proportional to wall thickness (h): σ = (ΔP × r) / (2h). As the aorta dilates from 3 cm to 6 cm, radius doubles while wall thickness actually decreases due to thinning from proteolysis, resulting in quadrupling of wall stress. This vicious cycle drives progressive dilation—the larger the aneurysm, the greater the hemodynamic stress on an already-weakened wall, promoting further expansion at an accelerating rate. This biomechanical principle directly informs clinical decision-making regarding intervention thresholds.

• Thrombosis and Intramural Hematoma: Large AAAs frequently contain intraluminal thrombus (ILT), which is not merely passive clot but an active inflammatory nidus secreting additional MMPs and inflammatory cytokines. ILT may insulate portions of the aortic wall from shear stress, potentially increasing expansion rates in some segments. Rupture can involve dissection planes within the aortic wall (intramural hematoma) or frank full-thickness rupture; the former sometimes presents as contained rupture with relative hemodynamic stability if contained by the adventitia and surrounding tissues.

• Atherosclerotic Degeneration (Most Common, 90% of cases): Chronic atherosclerotic inflammation and medial degeneration drive most AAAs. Atherosclerotic lesions themselves contribute oxidative stress and inflammatory mediators that promote local proteolysis. Strong associations exist with traditional cardiovascular risk factors: smoking (up to 15-fold increased risk, dose-dependent), hypertension (2-4 fold risk), hyperlipidemia, and male sex. The mechanism links atherosclerotic plaque formation, local inflammatory activation, and subsequent aneurysmal degeneration of the underlying media. Notably, the severity of intraluminal atherosclerosis does not correlate with aneurysm size, suggesting that medial degeneration rather than luminal disease is the primary driver.

• Smoking (Strongest Modifiable Risk Factor): Tobacco smoke delivers over 4000 chemicals including oxidants and free radicals that directly damage elastic fibers and activate inflammatory pathways. Smoking increases MMP-9 levels and impairs TIMP function. Former smokers retain some elevated risk for years after cessation. Smoking acceleration of AAA growth is approximately 0.2-0.3 cm per year in smokers versus 0.1-0.15 cm per year in non-smokers—a two-fold acceleration.

• Chronic Hypertension: Sustained elevations in aortic pressure accelerate proteolysis and medial degeneration. Hypertension amplifies wall stress via Laplace mechanics, creating a permissive environment for aneurysm expansion. Blood pressure control reduces AAA growth rates and may lower rupture risk, though intervention thresholds are not definitively altered.

• Advanced Age and Male Sex: AAA prevalence increases exponentially with age >65 years. Male predominance is partly attributable to estrogen's protective effects on elastic fiber integrity and inflammatory modulation; estrogen deficiency (post-menopausal) increases AAA risk in women. Genetic factors underlying male predisposition remain incompletely understood.

• Family History and Genetic Factors: 15-25% of AAA patients report a positive family history. Familial AAA clustering suggests genetic predisposition, though most cases do not follow Mendelian inheritance. Rare genetic syndromes associated with AAA include Marfan syndrome (fibrillin-1 mutations causing elastic fiber defects), Ehlers-Danlos syndrome (collagen deficiency), and Loeys-Dietz syndrome (TGFB receptor mutations), though these account for <5% of AAAs. GWAS studies have identified genetic loci associated with AAA susceptibility, including regions near MMPs and inflammatory mediators.

• Chronic Obstructive Pulmonary Disease (COPD): Patients with emphysema show accelerated AAA expansion (possibly due to shared elastin-destructive pathways with smoking). COPD is independently associated with AAA independent of smoking history, suggesting shared proteolytic mechanisms.

• Inflammatory Aortitis (Less Common, 5-10% of cases):
• Infectious aortitis: Bacterial infection (syphilis historically; currently Salmonella, Staphylococcus in immunocompromised hosts) or tuberculosis can damage the aortic wall, creating mycotic aneurysms with propensity for rapid expansion and rupture.
• Non-infectious inflammatory aortitis: Takayasu arteritis and giant cell arteritis (GCA) primarily affect the ascending aorta and arch but can involve descending thoracic/abdominal aorta. GCA-associated aortic disease presents in elderly patients with systemic inflammatory markers (elevated ESR/CRP).

• Connective Tissue Disorders: Marfan syndrome (fibrillin-1 defects), Ehlers-Danlos syndrome (Type IV most associated with vascular complications), and Loeys-Dietz syndrome feature defective elastic and collagenous matrices predisposing to aortic aneurysm, often at younger ages and with particular risk for dissection. These syndromes warrant prophylactic repair at smaller diameters (typically ≥5.0 cm).

• Chronic Kidney Disease and Dialysis: Uremia and mineral metabolism abnormalities (phosphate retention, altered calcium-phosphate balance) promote vascular calcification and remodeling. Dialysis patients show accelerated aortic disease progression.

• Hypercholesterolemia and Metabolic Syndrome: Dyslipidemia contributes to local inflammation and oxidative stress within the aortic wall.

• Asymptomatic AAA (Detected on Screening, ~75-80% at diagnosis): The majority of AAAs are discovered incidentally on imaging performed for other reasons or during screening in high-risk populations. Asymptomatic AAAs progress silently; growth rates average 0.3-0.4 cm per year but are highly variable. Larger baseline diameter, smoking status, and elevated blood pressure predict faster expansion. Patients with asymptomatic AAAs ≤5.5 cm are managed conservatively with serial imaging surveillance, while those >5.5 cm or with rapid expansion (>0.5 cm/6 months) warrant elective intervention.

• Symptomatic AAA (Warning Signs of Rupture Risk, 15-20% at presentation): Abdominal or back pain in a patient with known or suspected AAA mandates urgent evaluation for impending rupture. The pain is typically sudden in onset, severe, and constant. Back pain (lumbar or sacral region) suggests irritation of retroperitoneal structures or contained rupture. Flank pain may indicate lateral wall rupture contained by the psoas fascia. Groin or inguinal pain can result from rupture extending inferiorly. Importantly, pain does NOT reliably distinguish contained from free rupture; absence of hemodynamic instability does not exclude imminent rupture.

• Contained Rupture (Hemodynamically Relative Stable, Critical Time Window): A contained rupture occurs when aortic rupture is limited by surrounding tissues (adventitia, retroperitoneal fascia, psoas muscle) that temporarily tamponade bleeding. These patients present with severe, acute abdominal or back pain often with hypotension but without profound shock. Contained rupture represents a surgical emergency with a critical time window (hours) before decompensation into free rupture and profound hemorrhage. Imaging may show blood extending into the retroperitoneum or perivascular space. Mortality from contained rupture is 30-50% even with immediate surgery, versus >80% for free rupture, emphasizing the temporal criticality of diagnosis.

• Free Rupture (Hemodynamic Collapse): Rupture extending beyond containing tissues results in rapid intra-abdominal or retroperitoneal hemorrhage. Patients present with classic triad: sudden severe abdominal/back pain, hypotension, and a pulsatile abdominal mass. However, this classic triad occurs in only ~50% of cases; absence of any element does not exclude rupture. Hemorrhagic shock ensues rapidly, with altered mental status, cool extremities, and oliguria. The mortality of free rupture is extraordinarily high (>80% overall, >90% in those not reaching the operating room); only 10-15% of patients with ruptured AAA who arrive at the hospital alive survive to discharge.

• Abdominal Pain (Cardinal Symptom)
• Mechanism: Pain results from stretching of the peritoneum and retroperitoneal tissues by an expanding aneurysm or acute rupture. Inflammatory mediators released from the aneurysm wall may also contribute to visceral pain.
• Characteristics: The pain is typically described as deep, constant, and severe, often radiating to the back, flanks, or groin. In symptomatic AAA without rupture, pain may be self-limited or fluctuating; in rupture, pain is immediate and maximal.
• Clinical pearl: Any patient >50 years with new onset abdominal or back pain should prompt consideration of AAA, particularly with risk factors (smoking, hypertension, male sex).

• Hemodynamic Instability (Hypotension, Shock)
• Mechanism: Acute blood loss from rupture overwhelms compensatory mechanisms; initially, sympathetic activation increases heart rate and peripheral vasoconstriction, but massive hemorrhage rapidly depletes intravascular volume, resulting in distributive shock and organ hypoperfusion.
• Clinical significance: Blood pressure <90 mmHg systolic in a patient with suspected AAA rupture indicates decompensated hemorrhagic shock; surgery must proceed emergently without diagnostic delay. Even relative hypotension (baseline 160 mmHg, presenting at 120 mmHg) warrants urgent evaluation.

• Pulsatile Abdominal Mass
• Physical exam finding: A palpable, expansile (pulsatile) mass anterior to the peritoneum in the midline or left abdomen suggests AAA. Sensitivity of bedside palpation is only 50-60% for AAA ≥5 cm and even lower for smaller aneurysms (sensitivity <50% for AAA 3-5 cm), making absence of a palpable mass an unreliable exclusion criterion. Specificity is high (>95%), meaning if a pulsatile mass is clearly felt, AAA is likely present.
• Pitfall: Obese patients, ascites, or anterior abdominal wall pathology may obscure palpation. Hyperactive aorta in thin patients with normal systolic pulse pressure may mimic aneurysm. Distinguish true aneurysm (expansile pulsations in transverse diameter) from transmitted pulsation (aortic pulsation without transverse expansion).

• Femoral Pulse Abnormalities
• Finding: Diminished or absent femoral pulses may indicate iliac artery involvement or dissection from rupture extending into iliac vessels.

• Lower Extremity Ischemia (Acute)
• Mechanism: Rupture extending into iliac arteries can thrombose or occlude these vessels, causing acute lower extremity ischemia with pain, pallor, pulselessness, paresthesias, and paralysis (five P's). This is a rare but catastrophic presentation.

• Atypical Presentations (Diagnostic Traps)
• Syncope without pain: Rarely, AAA rupture presents with sudden cardiovascular collapse and syncope without preceding pain, likely due to acute IVC rupture with massive blood loss causing sudden cardiogenic shock.
• Hemodynamic instability with minimal pain: Some patients develop shock from rupture with surprisingly mild pain, delaying diagnosis; a high index of suspicion is essential in hypotensive patients with abdominal complaints.
• Presentation mimicking other emergencies: AAA can masquerade as acute coronary syndrome (referred back pain), acute MI (epigastric pain with diaphoresis), renal colic (flank pain), or acute pancreatitis (upper abdominal pain with elevated lipase), leading to misdiagnosis and delayed surgical intervention. Imaging is mandatory.

• Clinical History and Risk Factor Assessment
• Establish age (>50 years), smoking history (current most significant), hypertension history, family history of AAA or sudden death, COPD, previous vascular disease.
• Characterize pain: sudden vs gradual onset, severity, location (anterior abdomen vs back/flank), radiation, associated symptoms (hemodynamic, neurologic).
• Duration of symptoms; acute pain suggestive of rupture or expansion.
• Diagnostic criterion: High clinical suspicion (age >55, smoking, hypertension) with acute abdominal

Unstable / suspected rupture — resuscitate and operate

• Immediate priorities: two large-bore IVs, type and crossmatch, activate massive transfusion protocol with balanced blood product resuscitation, and transfer directly to the operating room. The Society for Vascular Surgery (SVS) endorses permissive hypotension — titrating to a systolic pressure that preserves mentation rather than normalizing blood pressure — because aggressive crystalloid raises pressure, dilutes clotting factors, and dislodges the fragile contained hematoma.
• Do not delay for imaging in the hemodynamically unstable patient; bedside ultrasound suffices. CTA is reserved for the stable patient in whom it will change the operative plan.

Definitive repair (SVS 2018 AAA guideline; 2022 ACC/AHA Aortic Disease Guideline)

• Endovascular aneurysm repair (EVAR): preferred when anatomy permits (adequate infrarenal neck length, limited angulation, suitable iliac access). Lower perioperative mortality than open repair, but higher rates of late reintervention and mandatory lifelong imaging surveillance.
• Open repair with prosthetic graft: for unsuitable anatomy, young patients with long life expectancy, connective tissue disease, or infected (mycotic) aneurysm. Survival curves converge with EVAR over years.
• Repair thresholds: ≥5.5 cm in men, ≥5.0 cm in women, rapid expansion, or any symptomatic/ruptured aneurysm regardless of size — consistent with the surveillance framing already given.

Medical therapy for the small aneurysm under surveillance

• Smoking cessation: the only intervention convincingly shown to slow expansion and reduce rupture risk.
• Statins (e.g., atorvastatin) and antiplatelet therapy (aspirin): for global atherosclerotic risk reduction, not to shrink the aneurysm.
• Antihypertensives: ACC/AHA supports blood pressure control; beta blockers (e.g., metoprolol) are used for concomitant indications but trials did not show reduced AAA growth.

Avoid

• Fluoroquinolones: FDA warns against use in patients with aortic aneurysm given collagen degradation and dissection/rupture signal.
• Doxycycline and other "anti-MMP" strategies: not effective; do not select as therapy.
• Deferring repair in a symptomatic aneurysm below the size threshold — pain is an indication for urgent repair.

Complications of the disease

• Rupture (emergency): wall stress outstrips tensile strength per Laplace; free rupture presents with pain, hypotension, and pulsatile mass, contained retroperitoneal rupture with relative stability. Immediate operative control.
• Distal atheroembolism: intraluminal thrombus or atheromatous debris showers the digital arteries — blue toe syndrome with palpable pedal pulses and livedo. Pulses are preserved because the emboli are microscopic.
• Aortoenteric fistula (emergency): erosion into the third/fourth portion of the duodenum. Classic herald bleed — a self-limited GI hemorrhage preceding exsanguination. Suspect in any patient with GI bleeding and a prior aortic graft (secondary fistula).
• Aortocaval fistula: rupture into the IVC produces high-output heart failure, a continuous machinery-like abdominal bruit, and lower-extremity edema with pulsatile veins.
• Inflammatory AAA: dense periaortic fibrosis entraps the ureters — hydronephrosis, elevated ESR/CRP, weight loss.
• Acute thrombosis of the sac: sudden bilateral limb ischemia (five Ps).

Complications of repair

• Endoleak (EVAR-specific): persistent sac perfusion. Type I (proximal/distal seal failure) and type III (component separation/fabric tear) are high-pressure and require prompt reintervention; type II (retrograde flow from lumbar or inferior mesenteric arteries) is the most common and is usually observed unless the sac enlarges. Detected on lifelong surveillance CTA/duplex.
• Colonic ischemia (emergency): loss of inferior mesenteric artery/hypogastric flow injures the sigmoid watershed — bloody diarrhea within 48 hours of repair; flexible sigmoidoscopy is the diagnostic move.
• Perioperative myocardial infarction: the leading cause of non-hemorrhagic death after repair, reflecting the shared atherosclerotic substrate.
• Graft infection and pseudoaneurysm: fever, back pain, perigraft gas or fluid on CT.
• Contrast-induced nephropathy and renal failure: from EVAR contrast load or suprarenal clamping.
• Spinal cord ischemia: uncommon with infrarenal repair; presents as paraplegia with preserved posterior column function.
• Abdominal compartment syndrome (emergency) after ruptured-AAA repair: rising bladder pressures, oliguria, high airway pressures.

• Screening: the USPSTF recommends a one-time abdominal ultrasound in men aged 65–75 who have ever smoked (Grade B); selective offering in men 65–75 who never smoked (Grade C). It does not recommend routine screening in women who have never smoked. Ultrasound is the screening and surveillance modality of choice — no radiation, no contrast.
• Best next step depends on stability: unstable + suspected rupture → operating room (bedside ultrasound at most). Stable + symptomatic → CT angiography for operative planning. Ordering CT on a hypotensive patient is the classic wrong answer.
• The triad is unreliable: pain, hypotension, and pulsatile mass co-occur in only about half of ruptures. A normal abdominal exam never excludes AAA — palpation sensitivity is poor, especially in obese patients.
• The mimic examiners love: an older smoker with flank pain and hematuria "diagnosed" as renal colic. Ruptured AAA irritating the retroperitoneum reproduces this exactly; image the aorta before anchoring.
• Herald bleed: GI bleeding in a patient with a prior aortic graft is an aortoenteric fistula at the third/fourth portion of the duodenum until proven otherwise.
• Blue toe syndrome with intact pedal pulses = atheroembolism from mural thrombus, not large-vessel occlusion.
• Beta blockers do not slow AAA growth — a favorite distractor. Smoking cessation is the only proven modifier of expansion; statins and antiplatelets treat the atherosclerotic risk, not the aneurysm.
• Fluoroquinolones carry an FDA warning against use in patients with aortic aneurysm — the tempting antibiotic choice for a UTI in a patient with known AAA is the trap.
• EVAR trade-off: lower early mortality but obligatory lifelong surveillance imaging for endoleak; open repair has higher upfront risk with fewer late reinterventions.